Support for the role of mitochondrial dynamics in cancer progression comes from a study in lung cancer, where it was revealed that human lung cancer cell lines have imbalanced expression levels of Drp1/Mfn-2 that promote a state of fragmented mitochondria [30]. The gene discussed is MFN2; the disease is lung carcinoma.